Senior Editor, Consumer Health
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Malcolm Spicer
Sens. Pat Roberts, R-KS, and Heidi Heitkamp, D-ND, and Reps. Lynn Jenkins, R-KS and Ron Kind, D-WI, once again introduce the Restoring Access to Medications Act, proposing amending rather than repealing ACA.
Sen. Orrin Hatch and Rep. Erik Paulsen author the Health Savings Act of 2017 proposing a broad swath of changes to replace the ACA, including allowing dietary supplements as deductible medical expenses under pre-tax savings accounts and eliminating the Rx requirement to buy OTC drugs with the accounts.
FTC announces agreements to settle complaints against six of nine defendants identified in an investigation of XXL Impressions' advertising for CogniPrin promoted for cognitive benefits and FlexiPrin product promoted to reduce joint paint and rebuild damaged joints and cartilage.
Takeda says spinning off its consumer product portfolio into a wholly owned and independent subsidiary will boost its profile in the sector, but all signs continue to point to the firm's Rx operations as its predominant revenue drivers.
The manufacturer and retailer adds to its turnaround initiative a fee-based customer loyalty piece, "PRO Access," to replace its Gold Card program while also recovering customer traffic with its no-charge "myGNC Rewards" program.
Less than a month after investing in Italian nutritional supplement maker Akkadeas Pharma, Ipsen acquires five Sanofi OTC drug brands marketed in Europe, including Prontalgine analgesics available in France.